Phase II study of everolimus in refractory testicular germ cell tumors.
Mego M, Svetlovska D, Miskovska V, Obertova J, Palacka P, Rajec J, Sycova-Mila Z, Chovanec M, Rejlekova K, Zuzák P, Ondrus D, Spanik S, Reckova M, Mardiak J.
Mego M, et al. Among authors: mardiak j.
Urol Oncol. 2016 Mar;34(3):122.e17-22. doi: 10.1016/j.urolonc.2015.10.010. Epub 2015 Nov 21.
Urol Oncol. 2016.
PMID: 26612480
Clinical Trial.